Akèy › Ensifizyans kadyak › Indiana › South Bend
Etid klinik pou Ensifizyans kadyak nan South Bend, IN
5 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote South Bend (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Ap rekriteFaz 3
- Research Site, Elkhart · 14 mi lwen
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Ap rekriteFaz 3
- Midwest Cardiovascular Research and Education Foundation, Elkhart · 14 mi lwen
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Ap rekriteFaz 3
- Midwest Cardiovascular Research and Education Foundation, Elkhart · 14 mi lwen
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Ap rekriteFaz 3
- Midwest Cardiovascular Research And Education Foundation, Elkhart · 14 mi lwen
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Ap rekriteFaz 3
- Research Site, South Bend
Etid Ensifizyans kadyak nan lòt vil
- New York City, NY51 etid
- Boston, MA44 etid
- Dallas, TX42 etid
- Houston, TX36 etid
- Cleveland, OH33 etid
- Chicago, IL31 etid
- Philadelphia, PA31 etid
- San Francisco, CA29 etid
- St. Louis, MO26 etid
- Durham, NC26 etid
- Kansas City, MO25 etid
- Atlanta, GA25 etid
Lòt etid nan South Bend
- Kansè Poumon ki pa ti selil6 etid
- Maladi fwa steatotik5 etid
- Melanom5 etid
- Kansè nan tete5 etid
- Kansè poumon4 etid
- Kansè Endomèt3 etid
- Kansè renn (Kasinom selil renn)3 etid
- Kansè pankreyas3 etid
- Kansè ovè3 etid
- Kansè (tout kalite)3 etid
- Lukemi lenfositè kwonik3 etid
- Maladi kadyovaskilè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.